Ownership

13F as of Q2 2026 · 7.2M shares outstanding

Who owns CPMV?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

No insider has filed a notice of proposed sale (Form 144) for Mosaic Immunoengineering Inc in the last 12 months.

Diluted share count, FY2016–FY2024

+0.5%

+0.06% a year

Each share's claim on the business

−0.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.63M

over 9 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

No 13F manager reports holding CPMV.

Investment managers reporting CPMV on Form 13F

No 13F manager reports holding CPMV yet.

Mutual funds and ETFs reporting CPMV on Form N-PORT; together they hold 0.0% of the company

No fund reports holding CPMV yet.

Comments